The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

ResMed (RMD) stock is currently at a fascinating juncture. It is trading at a low price, and if you decide to invest in it, you are wagering on a company that is demonstrating reasonable growth, ...

INDIANAPOLIS (WISH) — Indiana Gov. Mike Braun announced Tuesday that health technology company Resmed will establish its first Midwest operation in Greenwood creating over 100 new jobs for Indiana.

GREENWOOD, Ind. — Officials with the Indiana Office of Commerce and the office of Indiana Gov. Mike Braun announced on Tuesday that a new company centered on health technology will establish its first ...

ResMed Inc. (NYSE:RMD) is one of the best medical technology stocks to invest in. On January 30, KeyBanc Capital Markets lifted its price target on ResMed Inc. (NYSE:RMD) to $302 from $299 and ...

Sydney: Sleep-breathing device maker ResMed plans to take global a doctor ‍education program aimed at promoting the screening of patients seeking Ozempic-style weight loss drugs for apnea, ⁠calling ...

Sleep apnea device maker ResMed will expand its American manufacturing operations and open a new facility in Indianapolis in 2027 but says it is not due to pressure from President Donald Trump for ...

ResMed’s 2030 strategy focuses on empowering 500 million lives by the end of the decade through its digital health products and cloud-based software solutions. The company reported that it has already ...

ResMed Inc. reported its Q4 2025 earnings, revealing a robust financial performance with revenue reaching $1.35 billion, surpassing the forecast of $1.33 billion. Despite this positive financial ...

Fractus, a company specializing in geometry-based antenna technology and IP licensing, has filed a patent infringement suit against respiratory leader ResMed. The complaint was filed in the United ...

ResMed, an ASX healthcare leader, is well-positioned to capitalise on the growing demand for sleep apnoea treatment and digital health solutions, offering potential long-term rewards. The company's ...

In fact he sees the opposite. “It’s not actually a headwind, it’s a tailwind,” the Resmed chief executive officer told The Australian ahead of being honoured by The American Australian Association at ...